The primary goal of the Transgenic Core is to provide Cancer Center members and other investigators at the Salk Institute access to cutting-edge technologies for creating genetically altered mouse models. These transgenic lines of mice represent critical genetic tools that enable researchers to model human diseases, to analyze and functionally manipulate specific genes, and to test potential therapeutic interventions. To achieve this goal, the Transgenic Core provides state-of-the genome editing services, as well as services required to generate and maintain transgenic mice. Specific services include: 1) the microinjection of DNA constructs into early mouse embryos, 2) CRISPR/Cas9 microinjections, 3) lentiviral microinjections, 4) microinjection of gene- targeted mouse embryonic stem (ES) cells into blastocysts, 5) in-vitro fertilization (IVF), 6) embryo and sperm cryopreservation, 7) re-derivation of mouse lines provided to the Institute from non-standard sources, 8) gene- targeting in mouse ES cells, 9) targeting vector design and construction, 10) de novo derivation of ES cell lines, 11) ES cell expansion and preparation for microinjection, and 12) the generation and maintenance of DR4 and CF1 mouse embryonic feeder cells. In addition, the Core offers services for the injection of human embryonic stem cell lines and induced pluripotent stem (iPS) cell lines into immunodeficient mice to assess their ability to form teratomas. Recently the Transgenic Core has expanded services to offer: Southern blot services for confirmation of gene targeting in modified ES cells, PCR-based genotyping of transgenic mice, and mycoplasma testing. Thus, the Transgenic Core seeks to facilitate research of Cancer Center members by generating genetically modified mouse models of cancer, cryopreserving mouse lines that are not currently in use, re-deriving mouse lines provided by non-standard sources, generatimg homologous recombination-based gene targeted mouse ES cell lines, providing free consultations to match current transgenic technologies to investigator needs, and providing free training in all procedures involved in producing transgenic animals.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014195-48
Application #
10114243
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1996-12-31
Project End
2024-01-31
Budget Start
2021-02-01
Budget End
2022-01-31
Support Year
48
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Salk Institute for Biological Studies
Department
Type
DUNS #
078731668
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Eichner, Lillian J; Brun, Sonja N; Herzig, S├ębastien et al. (2018) Genetic Analysis Reveals AMPK Is Required to Support Tumor Growth in Murine Kras-Dependent Lung Cancer Models. Cell Metab :
Dravis, Christopher; Chung, Chi-Yeh; Lytle, Nikki K et al. (2018) Epigenetic and Transcriptomic Profiling of Mammary Gland Development and Tumor Models Disclose Regulators of Cell State Plasticity. Cancer Cell 34:466-482.e6
Zarrinpar, Amir; Chaix, Amandine; Xu, Zhenjiang Z et al. (2018) Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism. Nat Commun 9:2872
Ramaswamy, Suvasini; Tonnu, Nina; Menon, Tushar et al. (2018) Autologous and Heterologous Cell Therapy for Hemophilia B toward Functional Restoration of Factor IX. Cell Rep 23:1565-1580
Hsu, Cynthia L; Lee, Elian X; Gordon, Kara L et al. (2018) MAP4K3 mediates amino acid-dependent regulation of autophagy via phosphorylation of TFEB. Nat Commun 9:942
Sonntag, Tim; Vaughan, Joan M; Montminy, Marc (2018) 14-3-3 proteins mediate inhibitory effects of cAMP on salt-inducible kinases (SIKs). FEBS J 285:467-480
Herzig, S├ębastien; Shaw, Reuben J (2018) AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol 19:121-135
Sweeney, Lora B; Bikoff, Jay B; Gabitto, Mariano I et al. (2018) Origin and Segmental Diversity of Spinal Inhibitory Interneurons. Neuron 97:341-355.e3
Hartmann, Phillipp; Hochrath, Katrin; Horvath, Angela et al. (2018) Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice. Hepatology 67:2150-2166
Glustrom, Leslie W; Lyon, Kenneth R; Paschini, Margherita et al. (2018) Single-stranded telomere-binding protein employs a dual rheostat for binding affinity and specificity that drives function. Proc Natl Acad Sci U S A 115:10315-10320

Showing the most recent 10 out of 457 publications